Abnormal fat distribution and use of protease inhibitors.
Carr
A
A
Samaras
K
K
Chisholm
D J
DJ
Cooper
D A
DA
D000005:Abdomen / Q000473:pathology; D000273:Adipose Tissue / Q000473:pathology*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D001823:Body Composition / Q000187:drug effects*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D011480:Protease Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D011480:Protease Inhibitors